The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Pathological complete response rates after neoadjuvant chemoradiation (CRT) for rectal cancer: Do novel agents have a role?
Muhammad Shaalan Beg
No relevant relationships to disclose
Jeffrey John Meyer
No relevant relationships to disclose
Xian-Jin Xie
No relevant relationships to disclose
Glen C. Balch
No relevant relationships to disclose
Amit G Singal
No relevant relationships to disclose